Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.91 USD | -1.04% | -4.50% | +3.24% |
Business Summary
Number of employees: 27
Managers
Managers | Title | Age | Since |
---|---|---|---|
Lisa Ricciardi
CEO | Chief Executive Officer | 64 | 19-02-28 |
John Doyle
DFI | Director of Finance/CFO | 46 | 23-04-30 |
Paul J. Tiseo
CTO | Chief Tech/Sci/R&D Officer | - | 22-10-10 |
Mary Hamby
CTO | Chief Tech/Sci/R&D Officer | - | - |
Anthony Caggiano
CTO | Chief Tech/Sci/R&D Officer | 54 | 19-03-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Lisa Ricciardi
CEO | Chief Executive Officer | 64 | 19-02-28 |
Brett Monia
BRD | Director/Board Member | 62 | 20-09-30 |
Ellen Richstone
BRD | Director/Board Member | 72 | 21-10-31 |
Jack Khattar
CHM | Chairman | 62 | 19-12-31 |
Peggy Wallace
BRD | Director/Board Member | 67 | 16-08-31 |
Aaron Fletcher
BRD | Director/Board Member | 44 | 14-12-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 40,039,220 | 35,015,125 ( 87.45 %) | 0 | 87.45 % |
Company contact information
Sector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.24% | 76.47M | |
-3.46% | 102B | |
+1.41% | 96.09B | |
+2.13% | 22.28B | |
-15.84% | 21.4B | |
-9.28% | 18.14B | |
-39.98% | 17.02B | |
-14.65% | 16.09B | |
+4.39% | 13.83B | |
+31.35% | 11.97B |
- Stock Market
- Equities
- CGTX Stock
- Company Cognition Therapeutics, Inc.